Global Biosimilar Monoclonal Antibodies Market: Trend Analysis and Forecast to 2022 - PowerPoint PPT Presentation

About This Presentation
Title:

Global Biosimilar Monoclonal Antibodies Market: Trend Analysis and Forecast to 2022

Description:

The report on Biosimilar Monoclonal Antibodies Market by Infinium Global Research analyzes over the period of 2016 to 2022. This report also provides detailed qualitative and quantitative analyses of the market dynamics, market size and future trends in Global Biosimilar Monoclonal Antibodies Market. It will help a lot of decision makers to develop strategies and find new opportunities in the Global Biosimilar Monoclonal Antibodies Market. – PowerPoint PPT presentation

Number of Views:22
Slides: 5
Provided by: sunilbhoye
Category: Other

less

Transcript and Presenter's Notes

Title: Global Biosimilar Monoclonal Antibodies Market: Trend Analysis and Forecast to 2022


1
(No Transcript)
2
Global Biosimilar Monoclonal Antibodies Market
Trend Analysis and Forecast to 2022
The report on Biosimilar Monoclonal Antibodies
Market by Infinium Global Research analyzes over
the period of 2016 to 2022. This report also
provides detailed qualitative and quantitative
analyses of the market dynamics, market size and
future trends in Global Biosimilar Monoclonal
Antibodies Market. It will help a lot of
decision makers to develop strategies and find
new opportunities in the Global Biosimilar
Monoclonal Antibodies Market. The Biosimilar
Monoclonal Antibodies Market is driven by
rituximab and infliximab submarkets, the
rituximab submarket is accounted as the highest
holding market share submarket and the infliximab
submarket will become the leading submarket by
2018 continuing its dominance until 2022. A
monoclonal antibody is a type of protein made in
the laboratory that can bind to substances in the
body, including cancer cells. A monoclonal
antibody is made so that it binds to only one
substance to treat different types of cancer.
There are several types of monoclonal antibodies
that are being used to treat certain types of
cancer. Laboratory production of monoclonal
antibodies is produced from clones of only one
cell which means that every monoclonal antibody
produced by the cell is the same due to which
they are called as biosimilar monoclonal
antibodies. Each monoclonal antibody recognizes
one particular protein. They work in different
ways depending on the protein they are
targeting, hence different monoclonal antibodies
are required to be made to target different types
of cancers. Get a Sample Report _at_
https//www.infiniumglobalresearch.com/Reports/Mak
eSampleRequest/72 Segments Covered The report
segments the global biosimilar monoclonal
antibodies market by drug class and by
application.The market segmentation based on
drug class includes, rituximab, infliximab,
abciximab, trastuzumab,
3
  • adalimumab, and bevacizumab. Moreover, based on
    application the biosimilar monoclonal antibodies
    market is segmented into oncology, chronic and
    auto immune diseases, growth hormone deficiency
    and infectious diseases.
  • Companies Profiled
  • Pfizer Inc
  • Novartis AG
  • Reliance Life Sciences
  • Allergan plc
  • Coherus BioSciences Inc
  • Biocon
  • Dr. Reddys Laboratories Ltd.
  • Boehringer Ingelheim GmbH
  • BioXpress Therapeutics SA
  • Intas Pharmaceuticals Limited
  • BIOCAD
  • Genor BioPharma Co. Ltd
  • Celltrion Inc
  • Make an Enquiry _at_ https//www.infiniumglobalresear
    ch.com/Reports/MakeEnquiryRequest/72 Key topics
    covered
  • Report Overview
  • Executive Summary

4
  • Global Biosimilar Monoclonal Antibodies Market
    Overview
  • Global Biosimilar Monoclonal Antibodies Market,
    by Drug Class, (USD Million) 2015 2022
  • Global Biosimilar Monoclonal Antibodies Market,
    by Application, (USD Million) 2015 2022
  • Global Biosimilar Monoclonal Antibodies Market,
    by Region, (USD Million) 2015 2022 7 Company
    Profiles
  • Click to View Complete Report _at_
    https//www.infiniumglobalresearch.com/healthcare_
    medical_devices/global_biosimilar_monoclonal_anti
    bodies_market
Write a Comment
User Comments (0)
About PowerShow.com